Form 4: Abbott Laboratories Director Acquires Stock Equivalent Units

Director John G. Stratton acquired 277 stock equivalent units of Abbott Laboratories on March 31, 2025, as part of director fees credited to a grantor trust.

Summary

• On March 31, 2025, John G. Stratton, a director of Abbott Laboratories, acquired 277 stock equivalent units.
• These units were credited to a stock equivalent unit account under a grantor trust.
• The units are related to director fees and will be paid in cash generally at age 65 or upon retirement from the board.
• The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
• The price of the stock equivalent units was $132.65.
• Following the transaction, Stratton beneficially owns 11,979 stock equivalent units, which includes units acquired through a dividend reinvestment feature.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it aligns director interests with shareholders.

Positives

• The acquisition of stock equivalent units aligns the director's interests with those of the shareholders.
• The dividend reinvestment feature further increases the director's stake in the company.

Industry Context

This filing is a routine disclosure of a director's acquisition of stock equivalent units, which is a common practice for compensating board members and aligning their interests with shareholders.

Comparison to Industry Standards

• Director compensation in the form of stock or stock equivalent units is a common practice among publicly traded companies, including Abbott's peers in the pharmaceutical and healthcare industries such as Johnson & Johnson (JNJ) and Pfizer (PFE).
• These companies often use similar mechanisms like grantor trusts and dividend reinvestment features to incentivize long-term value creation and align director interests with shareholder returns.
• The specific amount and structure of the compensation can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The acquisition of stock equivalent units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates

Keywords

Abbott Laboratories, Stock Equivalent Units, Director Fees, Grantor Trust, Beneficial Ownership, Form 4, Stratton, ABT